These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

602 related items for PubMed ID: 28349869

  • 1. Modulation of regulatory T cells by intranasal allergen immunotherapy in an experimental rat model of airway allergy.
    Moitra S, Datta A, Mondal S, Hazra I, Faruk SMO, Das PK, Basu AK, Tripathi SK, Chaudhuri S.
    Int Immunopharmacol; 2017 Jun; 47():9-19. PubMed ID: 28349869
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
    Möbs C, Slotosch C, Löffler H, Jakob T, Hertl M, Pfützner W.
    J Immunol; 2010 Feb 15; 184(4):2194-203. PubMed ID: 20048125
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
    Möbs C, Ipsen H, Mayer L, Slotosch C, Petersen A, Würtzen PA, Hertl M, Pfützner W.
    J Allergy Clin Immunol; 2012 Nov 15; 130(5):1108-1116.e6. PubMed ID: 23021882
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Responses of CD4(+) CD25(+) Foxp3(+) and IL-10-secreting type I T regulatory cells to cluster-specific immunotherapy for allergic rhinitis in children.
    Lou W, Wang C, Wang Y, Han D, Zhang L.
    Pediatr Allergy Immunol; 2012 Mar 15; 23(2):140-9. PubMed ID: 22192331
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Applications and mechanisms of immunotherapy in allergic rhinitis and asthma.
    Kappen JH, Durham SR, Veen HI, Shamji MH.
    Ther Adv Respir Dis; 2017 Jan 15; 11(1):73-86. PubMed ID: 27678500
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Human leukocyte antigen-G and regulatory T cells during specific immunotherapy for pollen allergy.
    Sørensen AE, Johnsen CR, Dalgaard LT, Würtzen PA, Kristensen B, Larsen MH, Ullum H, Søes-Petersen U, Hviid TV.
    Int Arch Allergy Immunol; 2013 Jan 15; 162(3):237-52. PubMed ID: 24022071
    [Abstract] [Full Text] [Related]

  • 19. Synthesized OVA323-339MAP octamers mitigate OVA-induced airway inflammation by regulating Foxp3 T regulatory cells.
    Su W, Zhong W, Zhang Y, Xia Z.
    BMC Immunol; 2012 Jul 06; 13():34. PubMed ID: 22769043
    [Abstract] [Full Text] [Related]

  • 20. How molecular diagnosis may modify immunotherapy prescription in multi-sensitized pollen-allergic children.
    Del-Río Camacho G, Montes Arjona AM, Fernández-Cantalejo Padial J, Rodríguez Catalán J.
    Allergol Immunopathol (Madr); 2018 Jul 06; 46(6):552-556. PubMed ID: 30017214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.